全文获取类型
收费全文 | 6967篇 |
免费 | 472篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 69篇 |
儿科学 | 145篇 |
妇产科学 | 155篇 |
基础医学 | 1012篇 |
口腔科学 | 458篇 |
临床医学 | 647篇 |
内科学 | 1592篇 |
皮肤病学 | 213篇 |
神经病学 | 620篇 |
特种医学 | 141篇 |
外科学 | 832篇 |
综合类 | 81篇 |
一般理论 | 2篇 |
预防医学 | 470篇 |
眼科学 | 159篇 |
药学 | 483篇 |
中国医学 | 16篇 |
肿瘤学 | 365篇 |
出版年
2023年 | 62篇 |
2022年 | 121篇 |
2021年 | 221篇 |
2020年 | 130篇 |
2019年 | 200篇 |
2018年 | 222篇 |
2017年 | 143篇 |
2016年 | 172篇 |
2015年 | 198篇 |
2014年 | 257篇 |
2013年 | 347篇 |
2012年 | 473篇 |
2011年 | 501篇 |
2010年 | 271篇 |
2009年 | 211篇 |
2008年 | 386篇 |
2007年 | 426篇 |
2006年 | 380篇 |
2005年 | 354篇 |
2004年 | 321篇 |
2003年 | 301篇 |
2002年 | 263篇 |
2001年 | 65篇 |
2000年 | 71篇 |
1999年 | 77篇 |
1998年 | 72篇 |
1997年 | 45篇 |
1996年 | 46篇 |
1995年 | 48篇 |
1994年 | 46篇 |
1993年 | 34篇 |
1992年 | 37篇 |
1991年 | 36篇 |
1990年 | 39篇 |
1989年 | 34篇 |
1988年 | 36篇 |
1987年 | 20篇 |
1985年 | 38篇 |
1984年 | 28篇 |
1983年 | 32篇 |
1982年 | 34篇 |
1981年 | 24篇 |
1980年 | 27篇 |
1979年 | 25篇 |
1978年 | 23篇 |
1976年 | 29篇 |
1944年 | 22篇 |
1943年 | 19篇 |
1913年 | 20篇 |
1912年 | 24篇 |
排序方式: 共有7460条查询结果,搜索用时 15 毫秒
81.
Efficacy of standard (SLA) and modified sandblasted and acid‐etched (SLActive) dental implants in promoting immediate and/or early occlusal loading protocols: a systematic review of prospective studies
下载免费PDF全文
![点击此处可从《Clinical oral implants research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
82.
83.
84.
Treatment escape reduces the effectiveness of cabergoline during long‐term treatment of acromegaly in monotherapy or in association with first‐generation somatostatin receptor ligands
下载免费PDF全文
![点击此处可从《Clinical endocrinology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
85.
Wadi Mawad Rajiv R. Chaturvedi Greg Ryan Edgar Jaeggi 《The Canadian journal of cardiology》2018,34(3):342.e9-342.e11
We report the first ultrasonographically guided percutaneous balloon atrial septoplasty (BAS), to our knowledge, in a fetus with transposition of the great arteries and an intact ventricular and atrial septum (37 + 2 weeks). After vaginal delivery at 38 weeks, the infant had an elective septostomy (day 1) and an arterial switch procedure (day 7), with an uneventful postoperative course. For centres with experience in fetal cardiac interventions, fetal BAS is a superior management option compared with the alternatives for this high-risk physiology. 相似文献
86.
87.
Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy
下载免费PDF全文
![点击此处可从《Clinical and experimental immunology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
A. Stubbs C. Bangs B. Shillitoe J. D. Edgar S. O. Burns M. Thomas H. Alachkar M. Buckland E. McDermott G. Arumugakani M. S. Jolles R. Herriot P. D. Arkwright 《Clinical and experimental immunology》2018,191(2):212-219
Immunoglobulin replacement therapy enhances survival and reduces infection risk in patients with agammaglobulinaemia. We hypothesized that despite regular immunoglobulin therapy, some patients will experience ongoing respiratory infections and develop progressive bronchiectasis with deteriorating lung function. One hundred and thirty‐nine (70%) of 199 patients aged 1–80 years from nine cities in the United Kingdom with agammaglobulinaemia currently listed on the UK Primary Immune Deficiency (UKPID) registry were recruited into this retrospective case study and their clinical and laboratory features analysed; 94% were male, 78% of whom had Bruton tyrosine kinase (BTK) gene mutations. All patients were on immunoglobulin replacement therapy and 52% had commenced therapy by the time they were 2 years old. Sixty per cent were also taking prophylactic oral antibiotics; 56% of patients had radiological evidence of bronchiectasis, which developed between the ages of 7 and 45 years. Multivariate analysis showed that three factors were associated significantly with bronchiectasis: reaching 18 years old [relative risk (RR) = 14·2, 95% confidence interval (CI) = 2·7–74·6], history of pneumonia (RR = 3·9, 95% CI = 1·1–13·8) and intravenous immunoglobulin (IVIG) rather than subcutaneous immunoglobulin (SCIG) = (RR = 3·5, 95% CI = 1·2–10·1), while starting immunoglobulin replacement after reaching 2 years of age, gender and recent serum IgG concentration were not associated significantly. Independent of age, patients with bronchiectasis had significantly poorer lung function [predicted forced expiratory volume in 1 s 74% (50–91)] than those without this complication [92% (84–101)] (P < 0·001). We conclude that despite immunoglobulin replacement therapy, many patients with agammaglobulinaemia can develop chronic lung disease and progressive impairment of lung function. 相似文献
88.
89.
90.
Livia M. Mermejo Leticia F. Leal Leandro M. Colli Maria C.B.V. Fragoso Ana C. Latronico Luiz G. Tone Carlos A. Scrideli Silvio Tucci Carlos E. Martinelli Jose A. Yunes Maria J. Mastellaro Ana L. Seidinger Silvia R. Brandalise Ayrton C. Moreira Leandra N. Ramalho Sonir R. Antonini Margaret Castro 《Clinical endocrinology》2014,81(4):503-510